Sarah Nanotechnology System for advanced solid tumors using heat therapy
Part of Cancer, Digestive system, Hormones & metabolism, Injuries & trauma, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial tests a new nanotechnology system that uses controlled heat to treat advanced solid tumors in the chest or abdomen that have not responded to standard treatments. It may be an option if you have few remaining choices and want to explore a novel approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumors in your chest or abdomen that have grown despite standard therapy and cannot be surgically removed.
- Your tumor is measurable on a scan and you have confirmed progression after your last cancer treatment.
- You are at least 18 years old, have a life expectancy of 90 days or more, and can do daily activities with little help.
- You have no metal or electronic implants in your body, including pacemakers, and your rib cage measures 90 cm or less.
- You have not had chemotherapy or radiation in the last 14 days, or immunotherapy or trial drugs in the last 21 days, and side effects from earlier treatments have resolved.
- You can lie flat with your arms above your head for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new therapy that combines heat treatment, a vaccine targeting a specific gene mutation, chemotherapy, and an immunotherapy drug to see if it can help people with advanced pancreatic cancer that has spread to the liver or lungs. It is for people whose cancer no longer responds to standard chemotherapy.
This trial tests a new drug called TS-104 for people with certain advanced solid tumors that have stopped responding to standard treatments. The drug is given alone (not with other cancer treatments) to see if it can shrink tumors or slow their growth.
This trial tests a new treatment that uses heat to target liver tumors and boost the immune system. It is for women with breast cancer that has spread to the liver who cannot have or do not want surgery.
This trial tests a new drug that may help people with advanced solid tumors that have not responded to other treatments. The drug is given as an injection and aims to stop cancer growth.
This trial tests a new drug, MB0151, for adults with advanced solid tumors that have somatostatin receptors and have not responded to standard treatments. It aims to see if MB0151 is safe and can shrink tumors.
This trial tests a new experimental treatment (SKL35501) that uses a special imaging agent (SKL35502) to find and target a marker called NTSR1 found on some advanced cancers. The goal is to see if this treatment is safe and can help people whose cancer has stopped responding to standard treatments.
Hear when a new Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.